This work is licensed under the Creative Commons Attribution 4.0 International License.
Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021;9(6):520.Cruz RodriguezJBOkajimaKGreenbergBHManagement of left ventricular thrombus: a narrative reviewAnn Transl Med20219652010.21037/atm-20-7839Search in Google Scholar
Camilli M, Lombardi M, Del Buono MG, et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021;7(3):e21–5.CamilliMLombardiMDel BuonoMGDirect oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysisEur Heart J Cardiovasc Pharmacother202173e21510.1093/ehjcvp/pvaa134Search in Google Scholar
Massussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):158–67.MassussiMScottiALipGYHProiettiRLeft ventricular thrombosis: new perspectives on an old problemEur Heart J Cardiovasc Pharmacother2021721586710.1093/ehjcvp/pvaa066Search in Google Scholar
Matsumoto M, Takei N, Mineki T, Yahata T, Oiwa K. Anticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarction. J Cardiol Cases. 2020;22(3):114–6.MatsumotoMTakeiNMinekiTYahataTOiwaKAnticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarctionJ Cardiol Cases2020223114610.1016/j.jccase.2020.05.012Search in Google Scholar
Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23):1743–9.DelewiRZijlstraFPiekJJLeft ventricular thrombus formation after acute myocardial infarctionHeart201298231743910.1136/heartjnl-2012-301962Search in Google Scholar
Keren A, Goldberg S, Gottlieb S, et al. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15(4):790–800.KerenAGoldbergSGottliebSNatural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarctionJ Am Coll Cardiol199015479080010.1016/0735-1097(90)90275-TSearch in Google Scholar
Weinsaft JW, Kim J, Medicherla CB, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc Imaging. 2016;9(5):505–15.WeinsaftJWKimJMedicherlaCBEchocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMRJACC Cardiovasc Imaging2016955051510.1016/j.jcmg.2015.06.017510433626476503Search in Google Scholar
Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75–84.SrichaiMBJunorCRodriguezLLClinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validationAm Heart J20061521758410.1016/j.ahj.2005.08.02116824834Search in Google Scholar
Barbieri A, Mantovani F, Bursi F, Faggiano A, Boriani G, Faggiano P. Optimal use of echocardiography in management of thrombosis after anterior myocardial infarction. Echocardiography. 2020;37(8):1287–95.BarbieriAMantovaniFBursiFFaggianoABorianiGFaggianoPOptimal use of echocardiography in management of thrombosis after anterior myocardial infarctionEchocardiography202037812879510.1111/echo.1480832757422Search in Google Scholar
Anwar AM, Nosir YFM, Ajam A, Chamsi-Pasha H. Central role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombi. Int J Cardiovasc Imaging. 2010;26(5):519–26.AnwarAMNosirYFMAjamAChamsi-PashaHCentral role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombiInt J Cardiovasc Imaging20102655192610.1007/s10554-010-9593-420131007Search in Google Scholar
Joseph P. Mathew, Ayoub, Chakib M., Alina Nicoara, and Madhav Swaminathan, Eds. Clinical Manual and Review of Transesophageal Echocardiography, Third edition. McGraw-Hill Education, New York, 2019.MathewJoseph P.AyoubChakib M.NicoaraAlinaSwaminathanMadhavEds.Clinical Manual and Review of Transesophageal EchocardiographyThird editionMcGraw-Hill EducationNew York2019Search in Google Scholar
Bulluck H, Chan MHH, Paradies V, et al. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson. 2018;20(1):72.BulluckHChanMHHParadiesVIncidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysisJ Cardiovasc Magn Reson20182017210.1186/s12968-018-0494-3622299130404623Search in Google Scholar
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529–55.O’GaraPTKushnerFGAscheimDD2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCirculation201312745295510.1161/CIR.0b013e3182742c8423247303Search in Google Scholar
Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236.KernanWNOvbiageleBBlackHRGuidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationStroke2014457216023610.1161/STR.000000000000002424788967Search in Google Scholar
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77.IbanezBJamesSAgewallS2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)Eur Heart J20183921197710.1093/eurheartj/ehx39328886621Search in Google Scholar
Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228.AmsterdamEAWengerNKBrindisRG2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146424e13922810.1016/j.jacc.2014.09.01725260718Search in Google Scholar
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–467.KleindorferDOTowfighiAChaturvediS2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke AssociationStroke2021527e36446710.1161/STR.000000000000037534024117Search in Google Scholar
Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S–47S.GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJAmerican College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelinesChest20121412 Suppl7S47S10.1378/chest.1412S3327806022315257Search in Google Scholar
Kontny F, Dale J, Abildgaard U, Hegrenaes L, Lem P, Morstøl T. Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin. Eur Heart J. 1993;14(8):1040–3.KontnyFDaleJAbildgaardUHegrenaesLLemPMorstølTAdverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparinEur Heart J19931481040310.1093/eurheartj/14.8.10408404934Search in Google Scholar
Ebrahimi M, Fazlinezhad A, Alvandi-Azari M, Abdar Esfahani M. Long-term clinical outcomes of the left ventricular thrombus in patients with ST-elevation anterior myocardial infarction. ARYA Atheroscler. 2015;11(1):1–4.EbrahimiMFazlinezhadAAlvandi-AzariMAbdar EsfahaniMLong-term clinical outcomes of the left ventricular thrombus in patients with ST-elevation anterior myocardial infarctionARYA Atheroscler201511114Search in Google Scholar
Mearns ES, White CM, Kohn CG, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014;12:14.MearnsESWhiteCMKohnCGQuality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regressionThromb J2014121410.1186/1477-9560-12-14409492625024644Search in Google Scholar
Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis. 2007;23(2):83–91.AnsellJHollowellJPengoVMartinez-BrotonsFCaroJDrouetLDescriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM)J Thromb Thrombolysis2007232839110.1007/s11239-006-9022-717221328Search in Google Scholar
Franco Moreno AI, Martín Díaz RM, García Navarro MJ. Direct oral anticoagulants: An update. Med Clin (Barc). 2018;151(5):198–206.Franco MorenoAIMartín DíazRMGarcía NavarroMJDirect oral anticoagulants: An updateMed Clin (Barc)2018151519820610.1016/j.medcle.2018.07.005Search in Google Scholar
Tran PN, Tran M-H. Emerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2018;24(2):201–9.TranPNTranM-HEmerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopeniaClin Appl Thromb Hemost2018242201910.1177/1076029617696582Search in Google Scholar
Cohen H, Efthymiou M, Isenberg DA. Use of direct oral anticoagulants in antiphospholipid syndrome. J Thromb Haemost. 2018;16(6):1028–39.CohenHEfthymiouMIsenbergDAUse of direct oral anticoagulants in antiphospholipid syndromeJ Thromb Haemost201816610283910.1111/jth.14017Search in Google Scholar
Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017;43(1):24–30.SkelleyJWWhiteCWThomasonARThe use of direct oral anticoagulants in inherited thrombophiliaJ Thromb Thrombolysis2017431243010.1007/s11239-016-1428-2Search in Google Scholar
Cochran JM, Jia X, Hamzeh I, Birnbaum Y. Abstract 16411: Direct oral anticoagulant use for left ventricular thrombus: a single-center experience. Circulation. 2018;138:A16411.CochranJMJiaXHamzehIBirnbaumYAbstract 16411: Direct oral anticoagulant use for left ventricular thrombus: a single-center experienceCirculation2018138A16411Search in Google Scholar
Fleddermann AM, Hayes CH, Magalski A, Main ML. Efficacy of direct-acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124(3):367–72.FleddermannAMHayesCHMagalskiAMainMLEfficacy of direct-acting oral anticoagulants in treatment of left ventricular thrombusAm J Cardiol201912433677210.1016/j.amjcard.2019.05.009Search in Google Scholar
Daher J, Da Costa A, Hilaire C, et al. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists. Clin Drug Investig. 2020;40(4):343–53.DaherJDa CostaAHilaireCManagement of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K AntagonistsClin Drug Investig20204043435310.1007/s40261-020-00898-3Search in Google Scholar
Guddeti RR, Anwar M, Walters RW, et al. Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study. Am J Med. 2020;133(12):1488–91.GuddetiRRAnwarMWaltersRWTreatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational studyAm J Med20201331214889110.1016/j.amjmed.2020.05.025Search in Google Scholar
Robinson A, Ruth B, Dent J. Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single-center experience. J Am Coll Cardiol. 2018;71(11):A981.RobinsonARuthBDentJDirect oral anticoagulants compared to warfarin for left ventricular thrombi: a single-center experienceJ Am Coll Cardiol20187111A98110.1016/S0735-1097(18)31522-5Search in Google Scholar
Smetana KS, Dunne J, Parrott K, et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series. J Thromb Thrombolysis. 2017;44(4):519–24.SmetanaKSDunneJParrottKOral factor Xa inhibitors for the treatment of left ventricular thrombus: a case seriesJ Thromb Thrombolysis20174445192410.1007/s11239-017-1560-728948507Search in Google Scholar
Ali Z, Isom N, Dalia T, et al. Direct oral anticoagulant use in left ventricular thrombus. Thromb J. 2020;18:29.AliZIsomNDaliaTDirect oral anticoagulant use in left ventricular thrombusThromb J2020182910.1186/s12959-020-00242-x759694433132763Search in Google Scholar
Robinson AA, Trankle CR, Eubanks G, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020;5(6):685–92.RobinsonAATrankleCREubanksGOff-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombiJAMA Cardiol2020566859210.1001/jamacardio.2020.0652717763932320043Search in Google Scholar
Alcalai R, Butnaru A, Moravsky G, et al. Apixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 2021; Jul 19;pvab057. doi: 10.1093/ehjcvp/pvab057. Online ahead of print.AlcalaiRButnaruAMoravskyGApixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trialEur Heart J Cardiovasc Pharmacother2021Jul19pvab057.10.1093/ehjcvp/pvab057Online ahead of print.34279598Open DOISearch in Google Scholar
Abdelnabi M, Saleh Y, Fareed A, et al. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol. 2021;77(12):1590–2.AbdelnabiMSalehYFareedAComparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial)J Am Coll Cardiol202177121590210.1016/j.jacc.2021.01.04933766266Search in Google Scholar
Michael F, Natt N, Shurrab M. Direct oral anticoagulants vs vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysis. CJC Open. 2021;3(9):1169–81.MichaelFNattNShurrabMDirect oral anticoagulants vs vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysisCJC Open20213911698110.1016/j.cjco.2021.04.007853123034712941Search in Google Scholar
Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375(25):2423–34.GibsonCMMehranRBodeCPrevention of bleeding in patients with atrial fibrillation undergoing PCIN Engl J Med20163752524233410.1056/NEJMoa161159427959713Search in Google Scholar
Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60.ValgimigliMBuenoHByrneRA2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)Eur Heart J20183932136010.1093/eurheartj/ehx41928886622Search in Google Scholar
Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther AdvCardiovasc Dis. 2017;11(8):203–13.HabashFVallurupalliSChallenges in management of left ventricular thrombusTher AdvCardiovasc Dis20171182031310.1177/1753944717711139593357928589748Search in Google Scholar